Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Frédéric Bernard's publication output changed over time?
ScholarIQpublication output · 1999–2025
Output declined50% over the shown period — from 2 works in 1999 to 1 in 2025.
2
1
1
1
1
1
1
1
1
1
1999200120032004200520062007201120152025
What are the most-cited papers on Frédéric Bernard?
ScholarIQmost cited works
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
Denis Caillot, Anne Thiébaut, Raoul Herbrecht, Stéphane de Botton, Arnaud Pigneux, Frédéric Bernard, Jérôme Larché, Françoise Monchecourt, S. Alfandari, L. Mahi
Cancer. 2007194 CitationsOPEN ACCESS
Some recent developments in mechanical activation and mechanosynthesis
Éric Gaffet, Frédéric Bernard, J.C. Niepce, F. Charlot, Christophe Gras, G. Le Caër, J.L. Guichard, P. Delcroix, Alain Mocellin, Olivier Tillement
S45305740. 1999173 Citations
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
Jean Donadieu, Frédéric Bernard, Max M. van Noesel, Mohamed Barkaoui, Odile Bardet, Rosamaria Mura, Maurizio Aricò, Christophe Piguet, Virginie Gandemer, Corinne Armari Alla, Niels Clausen, Éric Jeziorski, Anne Lambilliote, Sheila Weitzman, Jan‐Inge Henter, Cor van den Bos, the Salvage Group of the Histiocyte Society
Blood. 2015170 CitationsOPEN ACCESS
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
Frédéric Millot, André Baruchel, Joëlle Guilhot, Arnaud Petit, Thierry Leblanc, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Verite, Christian Berthou, Claire Galambrun, Frédéric Bernard, Karima Yacouben, Pierre Bordigoni, C. Edan, Yves Réguerre, Gérard Couillault, Françoise Méchinaud, Jean‐Michel Cayuela, François Guilhot
Journal of Clinical Oncology. 2011166 Citations
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction
Frédéric Bernard, Caroline Thomas, Y. Bertrand, Martine Münzer, Judith Landman Parker, Marie Ouache, V. Minard Colin, Yves Pérel, Pascal Chastagner, C. Vermylen, Jean Donadieu
European Journal of Cancer. 2005134 Citations
Related on ScholarIQ
Université de Strasbourg
Institution
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
Paper
Some recent developments in mechanical activation and mechanosynthesis
Paper
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
Paper
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
Paper
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction
Paper